AHA Scientific Sessions 2026 Abstract · Nov 2, 2026

Vigorous Exercise is Associated with Better Quality of Life in Adults with Hypertrophic Cardiomyopathy: Data from the Multinational Lifestyle and Exercise in HCM (LIVE-HCM) Study

By Lampert R, Cassedy A, Day S et al.

Background: The LIVE-HCM study found that vigorous exercise did not increase arrhythmic risk in hypertrophic cardiomyopathy (HCM) patients. This analysis assessed quality-of-life (QOL) in HCM patients who exercised vigorously compared to those who did not. Methods: HCM patients, age 18-60 years, were enrolled at 36 sites from 2015-2022 and reported baseline QOL scores with Short Form-36 [physical functioning (PF), role limit-physical, vitality, emotional functioning, role limit-emotional, social functioning, body pain, and general health (GH)]. Exercise intensity was defined as vigorous (≥6 Metabolic Equivalent Task > 2 mo/year) or non-vigorous. Covariates included demographic and clinical variables. General Linear Models were used to construct multivariable models for overt HCM patients only (69 phenotype negative excluded). Effect size was reported as Partial Eta ² (ɳ ² ). Results: Of 1,341 patients (age 43±12 years; 61% male), 537 exercised vigorously and 804 were in the non-vigorous exercise group. After controlling for other variables, vigorous exercise had a moderate positive association with higher PF (ɳ ² = 0.06), Vitality (ɳ ² = 0.07), and GH (ɳ ² = 0.09) (Table). Exercise restrictions by an MD had a moderate negative impact on PF (ɳ ² = 0.06) and GH (ɳ ² = 0.04). Conclusions: Among adults with HCM, vigorous exercisers and patients with fewer restrictions reported better PF and GH. These results should inform shared decision-making among providers and HCM patients considering vigorous exercise.

doi.org/10.1161/circ.154.suppl_1.5232Populations

AgingResearch.News